Bharat Biotech's corona vaccine Covaxin may get emergency use approval from the World Health Organization (WHO) between July and September. Bharat Biotech, the company that made it, has applied to WHO for this. If this happens, people who have had Covaxin since September will also be able to travel abroad. The company said that regulatory approvals for Covaxin are underway in 60 countries. These include America and Brazil most affected by Corona.
So far approved in 13 countries
The company said that the application has been given to WHO-Geneva for approval. Covaxin has been approved in 13 countries so far. Most of the countries are emphasizing the vaccination of the people coming here. Those who have not been vaccinated can travel with a negative report of the RT-PCR test.
The debate begins amid discussion of vaccine passport
Recently, British Prime Minister Boris Johnson indicated that an attempt could be made to reach a consensus on a vaccine passport during the G-7 conference. He proposes to make international travel easier, but it still has many problems. There are also many countries where due to manufacturing or other problems, vaccination has not reached full speed.
Covaxin is being talked about in this because it has not been approved by WHO then. Foreign universities and many countries have made such rules that people who have got the WHO-approved vaccine will be allowed to travel abroad without restrictions. The most affected by this will be the children studying in foreign universities, who have got Covaxin installed in India.
What is the importance of HO's emergency use approval?
The WHO's Emergency Use Listing examines the safety and effectiveness of a health product in a public health emergency such as a pandemic. WHO gave emergency use approval to Pfizer's vaccine on 31 December 2020, Oxford-AstraZeneca's vaccine on 15 February 2021, and Johnson & Johnson's vaccine on 12 March.
According to the WHO, because of the emergency, it is necessary to develop and approve medicines, vaccines, and diagnostic tools as soon as possible. That too while meeting the standards of safety, efficiency, and quality. This assessment ensures the usefulness of these products to a wider range of people during the pandemic.
Center changed rules for Coveshield
Earlier on Monday, the central government had issued a new guideline regarding vaccination for people going abroad. Under the new SOP, students and professionals studying abroad will be able to take the second dose of CoveShield anytime after 28 days. Earlier this rule was of 84 days i.e. (12- 16 weeks). This rule will not apply to people living in the country.
This rule for those going abroad till August 31
According to the new guidelines of the Center, only those who have taken the Covishield vaccine for traveling abroad will be given a vaccination certificate. It will be mandatory to mention the passport number on the vaccination certificate. This facility is for those above 18 years of age who want to travel abroad till 31st August. Soon this special arrangement for those traveling abroad will also be available on the Cowin platform.
WHO: WHO alerted on Omicron's new form BA.2.75, 30 percent cases increased in two weeks
The World Health Organization (WHO) has alerted India and some other countries with the confirmation of the new subform BA.2.75 of the Omicron variant of the corona. WHO Director-General Tedros
RSS: Will RSS be able to achieve this impossible goal? Sangh's big plan regarding UP-Bihar
Keeping in mind the next Lok Sabha elections, the opposition has also started throwing its dice. While Congress leader Rahul Gandhi is trying to increase his acceptability through Bharat Jodo Yatra,
LIC IPO: 4 big things related to LIC, if you intend to invest in the company's IPO, then first know them
The Government of India on Sunday filed a draft of documents (DRHP) with capital markets regulator SEBI to bring the Initial Public Offering (IPO) of Life Insurance Corporation of India (LIC) into the
Hindu temple on target in Australia: Hindustan Murdabad wrote on the walls of Melbourne's Swaminarayan Temple
There has been an attack at the Swaminarayan Temple in Melbourne, Australia. According to the report of Australia Today, this attack has been done by Khalistan supporters. Here unknown people damaged
Jaswinder Bhalla: Gippy Grewal is shocked by the death of Jaswinder Bhalla, saying- 'He was like a father to me'
Jaswinder Bhalla, a well-known actor and comedian of the Punjabi industry, passed away today on 22 August. The actor said goodbye to this world at the age of 65. This incident has caused a wave of
Rich investors of IRCTC are in shock, 30 thousand crore rupees drowned in two days
Indian Railway Catering and Tourism Corporation (IRCTC) investors, who had made rich in the stock market till a few days ago, have now got a big setback. The stock price of IRCTC has broken 50 percent
Coronavirus Updates: Corona cases reduced again in the country, 937 new cases came in 24 hours; Active patients also decreased
There has been a decrease in the cases of corona infection in the country. The Health Ministry said that 937 cases of coronavirus have been registered in the last 24 hours. According to the data
Pakistan: After the attack, Imran Khan decided to stop the march, and said - will start after recovery
Former Pakistan Prime Minister Imran Khan said on Friday that he is stopping his march in the capital Islamabad. He took this decision when one day an assailant opened fire on his convoy. Imran Khan
UGC: The rules of Central University will now apply in Deemed also, admission will be done based on merit of National Entrance Examination
In the deemed-to-be universities across the country, now the admissions in undergraduate and postgraduate will be done based on the merit of the National Entrance Examination. The same rules as the
Corona In Gurugram - 9 died due to corona, 83 new infected found
Gurugram. The outbreak of corona infection in the district has reduced considerably now, but the death toll of patients is not taking the name of decrease. In the same sequence, 9 patients died due to
